[1]
Anawalt BD, Diagnosis and Management of Anabolic Androgenic Steroid Use. The Journal of clinical endocrinology and metabolism. 2019 Jul 1; [PubMed PMID: 30753550]
[2]
Higgins JP,Heshmat A,Higgins CL, Androgen abuse and increased cardiac risk. Southern medical journal. 2012 Dec; [PubMed PMID: 23211503]
[3]
Penning R,Veldstra JL,Daamen AP,Olivier B,Verster JC, Drugs of abuse, driving and traffic safety. Current drug abuse reviews. 2010 Mar; [PubMed PMID: 20088818]
[5]
Kaushik M,Sontineni SP,Hunter C, Cardiovascular disease and androgens: a review. International journal of cardiology. 2010 Jun 25; [PubMed PMID: 19923015]
[6]
Graham MR,Davies B,Grace FM,Kicman A,Baker JS, Anabolic steroid use: patterns of use and detection of doping. Sports medicine (Auckland, N.Z.). 2008; [PubMed PMID: 18489196]
[7]
Sagoe D,Molde H,Andreassen CS,Torsheim T,Pallesen S, The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Annals of epidemiology. 2014 May; [PubMed PMID: 24582699]
[8]
Alquraini H,Auchus RJ, Strategies that athletes use to avoid detection of androgenic-anabolic steroid doping and sanctions. Molecular and cellular endocrinology. 2018 Mar 15; [PubMed PMID: 28130115]
[10]
Ip EJ,Barnett MJ,Tenerowicz MJ,Perry PJ, The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy. 2011 Aug; [PubMed PMID: 21923602]
[11]
Parkinson AB,Evans NA, Anabolic androgenic steroids: a survey of 500 users. Medicine and science in sports and exercise. 2006 Apr; [PubMed PMID: 16679978]
[12]
Givens ML,Deuster P, Androgens and Androgen Derivatives: Science, Myths, and Theories: Explored From a Special Operations Perspective. Journal of special operations medicine : a peer reviewed journal for SOF medical professionals. 2015 Fall [PubMed PMID: 26360363]
[13]
Kanayama G,Brower KJ,Wood RI,Hudson JI,Pope HG Jr, Anabolic-androgenic steroid dependence: an emerging disorder. Addiction (Abingdon, England). 2009 Dec; [PubMed PMID: 19922565]
[15]
Fink J,Schoenfeld BJ,Hackney AC,Matsumoto M,Maekawa T,Nakazato K,Horie S, Anabolic-androgenic steroids: procurement and administration practices of doping athletes. The Physician and sportsmedicine. 2019 Feb; [PubMed PMID: 30247933]
[16]
Christou MA,Christou PA,Markozannes G,Tsatsoulis A,Mastorakos G,Tigas S, Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis. Sports medicine (Auckland, N.Z.). 2017 Sep; [PubMed PMID: 28258581]
[17]
Baggish AL,Weiner RB,Kanayama G,Hudson JI,Lu MT,Hoffmann U,Pope HG Jr, Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation. 2017 May 23 [PubMed PMID: 28533317]
[18]
Kam PC,Yarrow M, Anabolic steroid abuse: physiological and anaesthetic considerations. Anaesthesia. 2005 Jul; [PubMed PMID: 15960720]
[19]
Vanberg P,Atar D, Androgenic anabolic steroid abuse and the cardiovascular system. Handbook of experimental pharmacology. 2010 [PubMed PMID: 20020375]
[20]
Urhausen A,Albers T,Kindermann W, Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart (British Cardiac Society). 2004 May [PubMed PMID: 15084541]
[21]
Christoffersen T,Andersen JT,Dalhoff KP,Horwitz H, Anabolic-androgenic steroids and the risk of imprisonment. Drug and alcohol dependence. 2019 Oct 1; [PubMed PMID: 31421475]
[22]
Ip EJ,Lu DH,Barnett MJ,Tenerowicz MJ,Vo JC,Perry PJ, Psychological and physical impact of anabolic-androgenic steroid dependence. Pharmacotherapy. 2012 Oct; [PubMed PMID: 23033230]
[23]
Kanayama G,Hudson JI,DeLuca J,Isaacs S,Baggish A,Weiner R,Bhasin S,Pope HG Jr, Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. Addiction (Abingdon, England). 2015 May [PubMed PMID: 25598171]
[24]
Rasmussen JJ,Selmer C,Østergren PB,Pedersen KB,Schou M,Gustafsson F,Faber J,Juul A,Kistorp C, Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study. PloS one. 2016 [PubMed PMID: 27532478]
[25]
Kanayama G,Pope HG,Hudson JI, Associations of anabolic-androgenic steroid use with other behavioral disorders: an analysis using directed acyclic graphs. Psychological medicine. 2018 Nov [PubMed PMID: 29490719]
[26]
Ha ET,Weinrauch ML,Brensilver J, Non-ischemic Cardiomyopathy Secondary to Left Ventricular Hypertrophy due to Long-term Anabolic-androgenic Steroid Use in a Former Olympic Athlete. Cureus. 2018 Sep 17 [PubMed PMID: 30473946]
[27]
Akbari Z,Esmailidehaj M,Avarand E,Shariati M,Pourkhalili K, Ischemic Preconditioning Efficacy Following Anabolic Steroid Usage: A Clear Difference Between Sedentary and Exercise-Trained Rat Hearts. Cardiovascular toxicology. 2018 Dec 7 [PubMed PMID: 30535662]
[28]
Chistiakov DA,Myasoedova VA,Melnichenko AA,Grechko AV,Orekhov AN, Role of androgens in cardiovascular pathology. Vascular health and risk management. 2018 [PubMed PMID: 30410343]
[29]
Vlad RA,Hancu G,Popescu GC,Lungu IA, Doping in Sports, a Never-Ending Story? Advanced pharmaceutical bulletin. 2018 Nov [PubMed PMID: 30607326]
[30]
Ganson KT,Cadet TJ, Exploring Anabolic-Androgenic Steroid Use and Teen Dating Violence Among Adolescent Males. Substance use & misuse. 2019 [PubMed PMID: 30572768]
[31]
Guzzoni V,Selistre-de-Araújo HS,Marqueti RC, Tendon Remodeling in Response to Resistance Training, Anabolic Androgenic Steroids and Aging. Cells. 2018 Dec 7 [PubMed PMID: 30544536]
[32]
Collomp K,Buisson C,Gravisse N,Belgherbi S,Labsy Z,Do MC,Gagey O,Dufay S,Vibarel-Rebot N,Audran M, Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender. Endocrine. 2018 Mar [PubMed PMID: 29322301]
[33]
Fink J,Schoenfeld BJ,Nakazato K, The role of hormones in muscle hypertrophy. The Physician and sportsmedicine. 2018 Feb [PubMed PMID: 29172848]